Newsfeeds - Spark Newswire

1 minute read

Jefferies Initiates Coverage On GLOBALFOUNDRIES with Buy Rating, Announces Price Target of $87

Today, 5:04 AM

Jefferies analyst Mark Lipacis initiates coverage on GLOBALFOUNDRIES (NASDAQ:GFS) with a Buy rating and announces Price Target of $87.

GFS

8 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For November 9, 2021

By Benzinga Insights

Today, 5:04 AM

ADCT

1 minute read

Susquehanna Initiates Coverage On GLOBALFOUNDRIES with Positive Rating, Announces Price Target of $85

By Benzinga Newsdesk

Today, 5:04 AM

Susquehanna analyst Mehdi Hosseini initiates coverage on GLOBALFOUNDRIES (NASDAQ:GFS) with a Positive rating and announces Price Target of $85.

GFS

1 minute read

Arete Research Initiates Coverage On GLOBALFOUNDRIES with Sell Rating, Announces Price Target of $41

By Benzinga Newsdesk

Today, 5:04 AM

Arete Research initiates coverage on GLOBALFOUNDRIES (NASDAQ:GFS) with a Sell rating and announces Price Target of $41.

GFS

5 minute read

64 Biggest Movers From Yesterday

By Lisa Levin

Today, 5:04 AM

Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock is seeing increased interest by traders on social media. Also, the company filed a mixed shelf offering on Friday after the close.

ABVC

3 minute read

40 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 5:04 AM

Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares jumped 250% to $8.91 on abnormally-high volume. The stock is seeing increased interest by traders on social media. Also, the company filed a mixed shelf offering on Friday after the close.

ABVC

1 minute read

Jim Cramer Recommends Buying This Stock Following Recent IPO

By Craig Jones

Today, 5:04 AM

CNBC’s "Mad Money" host Jim Cramer advised investors to buy GlobalFoundries Inc (NASDAQ: GFS) following its IPO on Thursday.

GFS

3 minute read

28 Stocks Moving in Monday’s Pre-Market Session

By Lisa Levin

Today, 5:04 AM

Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) rose 333.9% to $11.02 in pre-market trading. ABVC Biopharma’s S-3 showed registration for $50 million mixed securities shelf offering.

ABVC